Should Surgery Be Part of the Multimodality Treatment for Stage IIIB Non-Small Cell Lung Cancer

被引:0
|
作者
Collaud, Stephane [1 ]
Provost, Bastien [1 ]
Fabre, Dominique [1 ]
Mussot, Sacha [1 ]
Besse, Benjamin [2 ]
Mercier, Olaf [1 ]
Fadel, Elie [1 ]
机构
[1] Marie Lannelongue Hosp, Le Plessis Robinson, France
[2] Gustave Roussy, Dept Canc Med, Villejuif, France
关键词
D O I
10.1016/j.jtho.2016.11.277
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA09.02
引用
收藏
页码:S576 / S576
页数:1
相关论文
共 50 条
  • [1] Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?
    Collaud, Stephane
    Provost, Bastien
    Besse, Benjamin
    Fabre, Dominique
    Le Chevalier, Thierry
    Mercier, Olaf
    Mussot, Sacha
    Fadel, Elie
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1570 - 1574
  • [2] Multimodality treatment of stage IIIA and IIIB non-small cell lung cancer
    Eberhardt, Wilfried
    Gauler, Thomas
    Poettgen, Christoph
    Krbek, Thomas
    Korfee, Soenke
    Stamatis, Georgios
    Stuschke, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (05) : S35 - S36
  • [3] Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer
    Pitz, CCM
    Maas, KW
    Van Swieten, HA
    de la Rivière, AB
    Hofman, P
    Schramel, FMNH
    ANNALS OF THORACIC SURGERY, 2002, 74 (01): : 164 - 169
  • [4] The role of surgery in the treatment of stage IIIB non-small cell lung cancer
    Grunenwald, Dominique H.
    EJC SUPPLEMENTS, 2007, 5 (05): : 263 - 267
  • [5] Guidelines on treatment of stage IIIB non-small cell lung cancer
    Jett, JR
    Scott, WJ
    Rivera, MP
    Sause, WT
    CHEST, 2003, 123 (01) : 221S - 225S
  • [6] Multimodality treatment in advanced stage non-small cell lung cancer
    Klikovits, T.
    Hoda, M. A.
    Ghanim, B.
    Aigner, C.
    Taghavi, S.
    Lang, G.
    Matilla, J.
    Klepetko, W.
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (17-18) : A21 - A21
  • [7] The multimodality therapy for patients with advanced non-small cell lung cancer (stage IIIB and IV).
    Guo, H
    Li, Z
    Cheng, H
    Sun, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 707S - 707S
  • [8] Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer
    DeCamp, MM
    Rice, TW
    Adelstein, DJ
    Chidel, MA
    Rybicki, LA
    Murthy, SC
    Blackstone, EH
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 126 (01): : 17 - 27
  • [9] Survival Impact of Surgery in the Treatment of Stage IIIB-IVA Non-Small Cell Lung Cancer
    Park, J. Y.
    Jang, S. H.
    Kim, H. I.
    Kim, J.
    Park, S.
    Hwang, Y. I.
    Jung, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S898 - S898
  • [10] Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer
    Jang, Seung Hun
    Park, Sojung
    Lee, Chang Youl
    Park, Ji Young
    Kim, Joo-Hee
    Park, Sunghoon
    Hwang, Yong Il
    Jung, Ki-Suck
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52